U.S. FDA approves Catalyst Pharma's rare disease drug [Reuters (UK)]
Solidion Technology, Inc. (STI)
Last solidion technology, inc. earnings: 10/17 06:00 am
Check Earnings Report
US:NYSE Investor Relations:
investors.suntrust.com/overview/default.aspx
Company Research
Source: Reuters
U.S. FDA approves Catalyst Pharma's rare disease drug | Reuters 2 Min Read (Reuters) - The U.S. Food and Drug Administration approved on Wednesday Catalyst Pharmaceuticals Inc’s drug to treat a rare autoimmune disease. The drug, Firdapse, becomes the first approved treatment for Lambert-Eaton Myasthenic Syndrome (LEMS), a rare neuromuscular disease which is estimated to affect three people per million worldwide. In patients with LEMS, the immune system attacks connections between nerves and muscles causing signal disruptions between the two. The FDA said LEMS may be associated with other autoimmune diseases, but more commonly occurs in patients with cancer such as small cell lung cancer. ( bit.ly/2BFqbGl ) “There are drugs that are used off label to treat LEMS symptoms here in the U.S. with varying degrees of efficacy and tolerability, but with respect to approved drugs, it is the first approval and there aren’t any competing drugs in development for LEMS either,” Oppenheimer analyst
Show less
Read more
Impact Snapshot
Event Time:
STI
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
STI alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
STI alerts
High impacting Solidion Technology, Inc. news events
Weekly update
A roundup of the hottest topics
STI
News
- Solidion Technology Reports Results for Full Year 2023 [Yahoo! Finance]Yahoo! Finance
- Solidion Technology Reports Results for Full Year 2023GlobeNewswire
- Solidion Technology, Inc. Announces Pricing of $3.85 Million Private Placement [Yahoo! Finance]Yahoo! Finance
- Solidion Technology, Inc. Announces Pricing of $3.85 Million Private PlacementGlobeNewswire
- Solidion Technology's Lithium-Sulfur Batteries on a Launch Pad to Accelerate the Takeoff of the eVTOL Aircraft Industry [Yahoo! Finance]Yahoo! Finance
STI
Sec Filings
- 4/19/24 - Form 8-K
- 4/15/24 - Form S-1
- 4/12/24 - Form 10-K
- STI's page on the SEC website